A population-based cancer registry run by Peru's national cancer institute, INEN, covering Lima and Callao. Its latest report, volume 6, counted 70,162 new invasive cancers in 2013 to 2015, an age-standardised rate of 225.8 per 100,000, and 32,572 cancer deaths.
The Registro de Cáncer de Lima Metropolitana is a population-based registry kept by the Departamento de Epidemiología y Estadística del Cáncer, one of the five departments of INEN's Dirección de Control del Cáncer. It began in 1968 with the whole of Metropolitan Lima (the provinces of Lima and Callao) as its area, stopped in 1978 and was restarted in 1990 at the Maes-Heller cancer research centre with funding from the Fundación Peruana de Cáncer; since 1990 it has published reports for 1990 to 1991, 1990 to 1993, 1994 to 1997, 1998, 2004 to 2005, 2010 to 2012 and 2013 to 2015. Cases come from Ministry of Health hospitals, EsSalud, the armed forces and police hospitals and private clinics, and from pathology and haematology laboratories and private practices, in Lima and Callao. Volume 6 (Lima, 2021) covers 2013 to 2015 for an estimated population of 9,751,717 over 2,811.65 square kilometres. It registered 75,418 new cancers, of which 70,162 were invasive (31,440 in men and 38,722 in women) and 5,256 in situ, with an age-standardised incidence of 225.8 per 100,000 (224.4 in men, 230.8 in women), histological verification of 81.6%, and 32,572 cancer deaths, an age-standardised mortality of 101.7 per 100,000 (112.5 in men, 94.6 in women). Leaving aside non-melanoma skin cancer, breast (43.15 per 100,000 women), cervical (21.99), stomach, thyroid and colon cancer led in women; prostate (45.12 per 100,000 men), stomach (19.39), lung, non-Hodgkin lymphoma and colon in men. Stomach cancer was the leading cause of cancer death in both sexes together. The report states that its 2010 to 2012 data were included in Cancer Incidence in Five Continents volume XI and that the registry has been an active member of the International Association of Cancer Registries since 1990. The 2022 regulation of the national cancer law charges the Ministry, through INEN, with building a national cancer registry that draws on population-based registries such as this one and on hospital registries.
The authors conclude that one minus the mortality-incidence ratio is an appropriate way to approximate five-year survival for these ten cancers in Lima. The registry's 2013 to 2015 report tabulates that figure for each cancer.
It sets out why Peru's national cancer figures are still estimates built from two cities' registries and death records, and what the country would need to measure cancer nationally.
Shares Ministerio de Salud del Perú (MINSA), Instituto Nacional de Enfermedades Neoplásicas, Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Shares Seguro Social de Salud (EsSalud), Peru, Ministerio de Salud del Perú (MINSA), Instituto Nacional de Enfermedades Neoplásicas.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares Ministerio de Salud del Perú (MINSA), Instituto Nacional de Enfermedades Neoplásicas.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/